NASDAQ:DXR Daxor Q2 2025 Earnings Report $10.62 -0.36 (-3.28%) Closing price 10/2/2026 03:59 PM EasternExtended Trading$10.73 +0.11 (+1.04%) As of 10/2/2026 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Daxor EPS ResultsActual EPS-$0.10Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/ADaxor Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/ADaxor Announcement DetailsQuarterQ2 2025Date3/2/2026TimeBefore Market OpensConference Call DateN/AConference Call TimeN/AConference Call ResourcesEarnings HistoryCompany Profile Daxor Earnings HeadlinesDaxor to Showcase Next-Gen Blood Volume Analyzer and New Clinical Data at HFSA 2026October 1 at 8:00 AM | globenewswire.comDaxor consensus price target decreased by 13.04% to $20.40September 15, 2026 | msn.comHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required. | Stansberry Research (Ad)Daxor Corporation to Participate in Lake Street’s Tenth Annual BIG10 Conference in New York CitySeptember 8, 2026 | quiverquant.comQDaxor Corporation to Participate in the 10th Annual Lake Street Best Ideas Growth ConferenceSeptember 8, 2026 | globenewswire.comDaxor Corporation CEO and President Michael Feldschuh Delivers 1st Half Corporate Update in Shareholder LetterSeptember 1, 2026 | globenewswire.comSee More Daxor Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Daxor? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Daxor and other key companies, straight to your email. Email Address About DaxorDaxor (NASDAQ:DXR) is a medical device company that develops and commercializes diagnostic technologies for measuring blood volume. Its primary product is the BVA-100 Blood Volume Analyzer, which uses an automated tracer-dilution technique to measure a patient’s total blood volume, red blood cell volume and plasma volume. The BVA-100 is designed to support clinical assessment and management in areas such as heart failure, critical care, blood disorders and other conditions in which a patient’s fluid or blood-volume status is important. By providing quantitative blood-volume information, the system is intended to help healthcare professionals evaluate fluid status and guide treatment decisions. Founded in 1972, Daxor is headquartered in New York and focuses on advancing blood-volume measurement technology for use by hospitals, medical centers and research institutions. The company is led by Chief Executive Officer Michael Feldschuh. Its operations and commercial reach are centered on the development and distribution of its medical diagnostic products.View Daxor ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Time to Nibble on MCD Stock After it Enters Oversold Territory?McCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal UpsideMicron’s Earnings Reveal Why the AI Memory Boom May Last LongerAnthropic's IPO Could Put Amazon's and Alphabet's Paper Profits to the TestBoeing’s Fighter Victory Opens the Door to Decades of Defense RevenueCorning and AT&T's $3 Billion Fiber Deal Reveals Where AI Spending Goes NextTarget's Holiday Blitz: Slashing Prices to Capture Market Share Upcoming Earnings PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
